Search

This new edition of Pharmacoresistance in Epilepsy addresses all issues relating to drug-resistance in epilepsy, including studies in patients as well in experimental models and presents the basis for an understanding of recent developments in the pathogenesis and treatment of this condition. Important issues associated with drug-resistant epilepsy are reviewed and updated, such as abnormalities in inhibitory mechanisms, neurotoxicity and changes the immune system associated with this disorder, and the development of drug-resistance as consequence of chronic exposure to antiseizure-medications. Considering that a major obstacle is that epilepsy associated with drug-resistance cannot be controlled with the traditional antiseizure medications, specific chapters describe therapeutic strategies to prevent or reduce the progression of the disease with complementary medical therapies, such as transcranial focal stimulation to promote neuroprotection. Pharmacoresistance in Epilepsy is a valuable resource for anyone working in the field, whether studying epilepsy in the lab or treating it in an office.

This book offers a detailed account of all aspects of photosensitive epilepsy, including genetic testing, functional imaging (fMRI, MEG), pharmacological studies, animal studies, classification based on the occurrence of photoparoxysmal responses (PPRs) in different epilepsy syndromes, and the available prevention and treatment options. In addition, the comorbidity of and overlap between migraine and epilepsy are discussed. Informative case histories with EEG examples and a helpful glossary are included. In epilepsy, the term photosensitivity is used both for epileptic seizures triggered by flashing or flickering light and for epileptiform discharges evoked by intermittent photic stimulation (IPS) during an EEG recording. Most patients with a clear history of visually induced seizures will show epileptiform EEG discharges during IPS (PPRs). As epileptiform discharges can be evoked in photosensitive patients at any time, without triggering seizures, theycan be considered a useful surrogate marker of the necessity and efficacy of epilepsy treatment. This book will serve as an ideal guide to the subject for pediatricians, (pediatric) neurologists, epileptologists, (child) psychiatrists, clinical geneticists, neuropsychologists, neuropharmacologists, occupational therapists, and basic scientists.

This book provides comprehensive information, both for clinicians and scientists, on the basic mechanisms, clinical features, and therapeutic approaches to epilepsy as an inflammatory disease. Inflammation has been for many years considered as an etiologic player (and a therapeutic target) for a specific group of epilepsies. However, it turns out that this concept underestimated the impact of inflammation in seizure disorders. Many accepted therapies for non-inflammatory epilepsies act in part as an inflammatory drug. The CNS actively responds to acute immune challenges by altering body temperature, stimulating the HPA axis, as well as up- and down-regulating specific sympathetic pathways.

This innovative book examines what can be learnt about the brain mechanisms underlying religious belief and practice from studying people with neurological disorders, such as stroke, epilepsy and Parkinson's disease. Using a clinical case study approach, the book analyses the interaction of social influences, religious upbringing and neurological disorders on lived religious experience in a number of different religions. The interdisciplinary contributors to the book ensure a variety of perspectives to help understand how the religious life is affected when different cognitive functions are impaired; how faith modifies the effects of neurological disorders; and how awareness of faith practices may assist in the treatment of these conditions.

The second edition of Neurobiology of Disease includes nearly 200 articles surveying all major disorders of the nervous system in both adults and children, focusing on relevant diagnosis and treatments from the perspective of cutting edge clinical and basic neurobiological research. Akin to an encyclopedia of every neurologic disorder, this comprehensive work is ideal for graduate and medical school students, residents, and candidates preparing for their board certification examinations. Each chapter is illustrated with detailed figures, supplemented with descriptive and diagnostic tables, and thoroughly referenced for further investigations. The book's editors, Michael V. Johnston, Harold P. Adams Jr., and Ali Fatemi bring their unique expertise in clinical and research neurology to the overall scope of this work. To further enhance the scope and quality of this new edition, the following Section Editors provided oversight of their respective sections: · Movement Disorders-Joel Perlmutter, Washington University · Dementias-David Knopman, Mayo Clinic · Motorneuron Diseases-Merit Cudkowicz, Massachusetts General Hospital · Paroxysmal Disorders-Solomon Moshe, Albert Einstein College of Medicine · Pediatric Neurology and Developmental Disorders-Tanjala Gipson and Deepa Menon, Kennedy Krieger Institute and Johns Hopkins University · Neuroimmunological Diseases-Carlos Pardo-Villamizar, Johns Hopkins University · Cerebrovascular Diseases-Harold P. Adams Jr., University of Iowa · Peripheral and Autonomic Nervous System Disorders and Pain-Nicholas Maragakis, Johns Hopkins University · Neoplastic and Paraneoplastic Diseases-Lisa DeAngelis, Memorial Sloan-Kettering Cancer Center · Infectious Diseases of the Nervous System-Karen L. Roos, Indiana University · Sleep Disturbances-Mark Dyken, University of Iowa · Substance Abuse and Toxicology Disorders-Barry E. Kosofsky, Weill-Cornell University Medical Center · Neurologic Manifestations of Medical Disorders-John C. Probasco, Johns Hopkins University